What's happening
This bill requires insurance policies to count third-party payments and assistance for prescription drugs toward an individual's out-of-pocket maximum and cost-sharing requirements.
Why it matters
Directly benefits patients who rely on financial assistance. (like manufacturer copay cards, charity funds, or coupons) by ensuring that this help counts toward their insurance deductibles and out-of-pocket limits, reducing their financial burden.
Prevents insurers from using “copay accumulator” programs. that previously ignored third-party assistance when calculating patients’ progress toward cost-sharing thresholds, which often led to unexpected and higher out-of-pocket costs for vulnerable patients.
Includes specific provisions to maintain compatibility with federal Health Savings Account (HSA) rules. , so people with HSA-qualified high-deductible plans remain eligible for tax advantages, while still gaining the bill’s protections once certain deductible requirements are met.
Mandates broad application across all types of insurance policies regulated by the state. , including individual, group, and blanket policies, so the protections would reach a wide range of New Yorkers with prescription drug coverage.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Count All Copay Help
Plain English, a few words. Used as the page title.
Sponsors
History
- Substituted by A1741A
- Amended on third reading 5299a
- Advanced to third reading
- 2nd report cal.
- 1st report cal.762
- Referred to insurance
- Returned to senate
- Died in assembly
- Referred to insurance
- Delivered to assembly
- Passed senateVote 62–1
- Advanced to third reading
Show 3 earlier actions
- 2nd report cal.
- 1st report cal.576
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Count All Copay Help
Signed by Governor · Sponsor Richard Gottfried
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
5299--A Cal. No. 762
2021-2022 Regular Sessions
IN SENATE
March 1, 2021
Introduced by Sens. RIVERA, ADDABBO, AKSHAR, BROOKS, COONEY, HOYLMAN, JACKSON, KENNEDY, KRUEGER, SALAZAR, SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Senate Rule 6, sec. 8 -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading
AN ACT to amend the insurance law, in relation to calculating an insured individual's overall contribution to any out-of-pocket maximum or any cost-sharing requirement
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 37 to read as follows:
(37) Any policy that provides coverage for prescription drugs shall apply any third-party payments, financial assistance, discount, voucher or other price reduction instrument for out-of-pocket expenses made on behalf of an insured individual for the cost of prescription drugs to the insured's deductible, copayment, coinsurance, out-of-pocket maximum, or any other cost-sharing requirement when calculating such insured individual's overall contribution to any out-of-pocket maximum or any cost-sharing requirement. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00472-02-2
§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 21 to read as follows:
(21) Every group or blanket policy delivered or issued for delivery in this state that provides coverage for prescription drugs shall apply any third-party payments, financial assistance, discount, voucher or other price reduction instrument for out-of-pocket expenses made on behalf of an insured individual for the cost of prescription drugs to the insured's deductible, copayment, coinsurance, out-of-pocket maximum, or any other cost-sharing requirement when calculating such insured individual's overall contribution to any out-of-pocket maximum or any costsharing requirement. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (tt) to read as follows:
(tt) Every contract issued by a medical expense indemnity corporation, hospital service corporation, or health service corporation that provides coverage for prescription drugs shall apply any third-party payments, financial assistance, discount, voucher or other price reduction instrument for out-of-pocket expenses made on behalf of an insured individual for the cost of prescription drugs to the insured's deductible, copayment, coinsurance, out-of-pocket maximum, or any other cost-sharing requirement when calculating such insured individual's overall contribution to any out-of-pocket maximum or any cost-sharing requirement. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.
§ 4. This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to all policies and contracts issued, renewed, modified, altered or amended on or after such date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to calculating an insured individual's overall contribution to any out-of-pocket maximum or any cost-sharing requirement
Purpose or general idea of bill
Requires insurance companies or pharmacy benefit managers to apply price reduction instruments for out-of-pocket expenses when calculating an insured individual's cost-sharing requirement.
Summary of provisions
Section 1 requires any individual insurance policy that provides cover- age for prescription drugs to apply any third party payments or other price reduction instruments for out-of-pocket expenses made on behalf of an insured person when calculating the insured individuals overall contribution to any out-of-pocket maximum or cost-sharing requirement.
Section 2 applies these same provisions to group or blanket policies that provide coverage for prescription drugs.
Section 3 applies these same provisions to non-profit medical expense indemnity policies, hospital service corporations or health service corporations that provide coverage for prescription drugs.
Should any of these requirements result in health savings account inel- igibility under federal law, they shall instead only apply to the deduc- tible after the required deductible threshold is met.
Justification
Recently, many insurance companies and pharmacy benefit managers have started to adopt new cost-shifting mechanisms that change the way an insured individual's out-of-pocket contributions for prescription drugs are calculated. These "copay accumulators" do not take into account any discounts or coupons that the insured person receives from the drug manufacturer when calculating the insured individuals out-of-pocket expenses.
Some insurance plans with a deductible require that the patient pay up to a certain amount of out-of-pocket expenses before the plan pays for all of the healthcare services. Many drug manufacturers, especially for high-cost drugs that treat rare diseases offer copay cards or other assistance to help pay for their prescription drugs.
By not applying the discounts paid by the manufacturer, it takes insured individuals longer to reach their deductible. This means that the insured person has to continue to pay copays for the drug for a longer period of time and may be paying significantly more in out-of-pocket expenses.
This practice shifts the cost towards patients as the insurance plan are essentially "double dipping" by requiring the patient to pay their normal copay and still receiving a discount or coupon from the drug manufacturer, while taking longer to satisfy their deductible. Several states have already prohibited copay accumulators including Arizona, Virginia and West Virginia. Several other states have introduced legis- lation (Connecticut, Illinois, California, and others) that is currently moving through the legislative process that either limit or prohibit the use of "copay accumulators" by insurers.
Prior legislative history
2021: S5299/A1741 Gottfried - Passed Senate
2019-2020: S6303/A8246 Gottfried - Passed Senate
Fiscal implications
None to the state.
Effective date
First of January next succeeding the date on which it shall become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.